Similar articles

• Cancer pain: pharmacological management (Part Two).

  Ghosn M, Gannage M. Ghosn M, et al. J Med Liban. 1993;41(4):244-8. J Med Liban. 1993. PMID: 7629826 Review. No abstract available.
• [Undertreatment of patients with pain has to be stopped. New therapeutic prospectives with retard tilin/naloxone].

  [No authors listed] [No authors listed] Anaesthesist. 1998 May;47(5 Suppl):1-4. Anaesthesist. 1998. PMID: 9646851 German. No abstract available.
• Controlling cancer pain with pharmacotherapy.

  Pharo GH, Zhou L. Pharo GH, et al. J Am Osteopath Assoc. 2007 Dec;107(12 Suppl 7):ES22-32. J Am Osteopath Assoc. 2007. PMID: 18165374 Review.
• [Current status of the treatment of chronic pain in oncological patients].

  Novikov GA, Prokhorov BM. Novikov GA, et al. Anesteziol Reanimatol. 1994 Jul-Aug;(4):63-8. Anesteziol Reanimatol. 1994. PMID: 7802324 Review. Russian. No abstract available.
• [Treatment of cancer pain: the role of co-analgesics].

  Mancini I, Body JJ. Mancini I, et al. Rev Med Brux. 1998 Sep;19(4):A319-22. Rev Med Brux. 1998. PMID: 9805965 French.